Leading global sovereign and technology investors from Ireland, Singapore, US and China back its data strategy to expand the reach and power of the leading global platform in genomics Major investments in Ireland aim to create the world's premier genomic and medical dataset, uniquely powered to accelerate drug discovery and deliver meaningful benefits of precision medicine to global patients SHANGHAI, CAMBRIDGE, Mass., DUBLIN and REYKJAVIK, Iceland, November 27, 2018-- WuXi NextCODE, the emerging global standard platform for genomic data, today announced the successful completion of a $200 million Series C financing.